Status:
COMPLETED
Impact of Self-monitoring of Blood Pressure and Self-titration of Medication in the Control of Hypertension (ADAMPA)
Lead Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Collaborating Sponsors:
Spanish Clinical Research Network - SCReN
Carlos III Health Institute
Conditions:
Hypertension
Adjustment
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The ADAMPA study is a pragmatic randomized clinical trial which aims to evaluate the effectiveness of an intervention based on self-monitoring and self-titration of medication in poorly controlled hyp...
Detailed Description
ADAMPA study. Objectives: To evaluate the comparative effectiveness of an intervention that includes educational components, self-monitoring of blood pressure and self-titration of antihypertensive me...
Eligibility Criteria
Inclusion
- 40 years or older
- Diagnosis of hypertension of any origin
- Systolic blood pressure (SBP) \> 145 or diastolic blood pressure (DBP) \> 90 mm Hg at baseline
- Voluntarily participation in the study and having signed the corresponding informed consent.
Exclusion
- Inability to understand and/or perform self-adjustment of the medication, including dementia or significant cognitive impairment (at the discretion of the investigator performing the recruitment).
- History of orthostatic hypotension (fall\> 20 mm Hg in SBP after adopting the orthostatic position).
- SBP\> 200 or DBP\> 100 mm Hg on the baseline examination
- Being on treatment with more than 4 antihypertensive drugs
- Participation in another study on high blood pressure or in a clinical trial
- Presence of tremor or neurological disease that makes it difficult to perform BP self-measurement.
- Presence of arrhythmia
- Presence of terminal illness
- Chronic disability impeding to leave home
- History of acute cardiovascular event in the last 3 months
- Hypertension managed directly by specialist physicians outside the primary care setting.
- Spouse selected for the study
- Non-resident or transient patients
- Pregnancy
Key Trial Info
Start Date :
July 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2020
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT03242785
Start Date
July 21 2017
End Date
August 25 2020
Last Update
August 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departamento de Salud Valencia Clínico Malvarrosa
Valencia, Spain